MRC Human Immunology Unit
We are a leading research centre in human immunology and the development of treatments against infectious diseases, cancer, allergy and autoimmune disease.
Xu X. et al, (2020), Proc Natl Acad Sci U S A, 117, 3718 - 3727
Chen Y-L. et al, (2020), J Exp Med, 217
A single cycle influenza virus coated in H7 haemagglutinin generates neutralizing antibody responses to haemagglutinin and neuraminidase glycoproteins and protection from heterotypic challenge.
Powell TJ. et al, (2019), J Gen Virol, 100, 431 - 445
Maelfait J. et al, (2020), J Mol Biol, 432, 552 - 568
Self-Maintaining CD103+ Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses.
Abd Hamid M. et al, (2020), Cancer Immunol Res, 8, 203 - 216
7 July 2020
A new study finds T cell immune response variation in recovered COVID-19 patients, including epitopes potentially important for vaccine design.
6 July 2020
A major UK research study into the long-term health impacts of COVID-19 on hospitalised patients has been launched.
9 June 2020
The study builds on a successful collaboration and will compare T cell and antibody responses to uncover the role of ‘background’ immunity to virus strains already in circulation, including infections with similar coronaviruses.